Covered recipient · General Payments record
MICHELLE REN LAUGLE
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2023
$1,628.20
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $326.67 | 18 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $134.33 | 8 |
| Janssen Biotech, Inc. | $69.60 | 3 |
| Lilly USA, LLC | $35.76 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $29.93 | 2 |
| Amgen Inc. | $21.27 | 1 |
| Exact Sciences Corporation | $21.06 | 1 |
| GlaxoSmithKline, LLC. | $14.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.99 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997731731 | CMS |
| ABBVIE INC. | $6.25 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997731733 | CMS |
| ABBVIE INC. | $4.65 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997731735 | CMS |
| ABBVIE INC. | $20.35 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997731737 | CMS |
| ABBVIE INC. | $19.39 | 09/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997731739 | CMS |
| ABBVIE INC. | $8.74 | 09/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997731741 | CMS |
| ABBVIE INC. | $24.59 | 11/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997731743 | CMS |
| ABBVIE INC. | $26.37 | 11/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997731745 | CMS |
| Amgen Inc. | $21.27 | 06/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020642471 | CMS |
| Exact Sciences Corporation | $21.06 | 08/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026646095 | CMS |
| GlaxoSmithKline, LLC. | $14.72 | 09/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002077371 | CMS |
| Janssen Biotech, Inc. | $20.75 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988491063 | CMS |
| Janssen Biotech, Inc. | $24.08 | 07/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988491041 | CMS |
| Janssen Biotech, Inc. | $24.77 | 10/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988491053 | CMS |
| Lilly USA, LLC | $15.12 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032034229 | CMS |
| Lilly USA, LLC | $20.64 | 08/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032086979 | CMS |
| Novartis Pharmaceuticals Corporation | $16.30 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992333035 | CMS |
| Novartis Pharmaceuticals Corporation | $13.63 | 11/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992333047 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.